Express News | UBS Group AG's Long Position in H-Shares of WuXi AppTec Increases to 5.63% on Dec 9 From 4.99% - HKEX

Reuters04:10 ET

WuXi AppTec Co. Announces Board of Directors Changes

TipRanksDec 12 05:39 ET

WUXI APPTEC (02359.HK) plans to nominate Leng Xuesong as an independent non-executive Director candidate.

On December 12, Gelonghui reported that WUXI APPTEC (02359.HK) announced that according to the relevant provisions of the "Administrative Measures for Independent Directors of Listed Companies", the term of office for independent directors of listed companies shall not exceed six years. Since independent non-executive director Feng Dai's term as independent director of the company will reach six years, he can no longer serve as the company's independent director. Accordingly, Feng Dai has notified the Board of Directors that he will resign from the position of independent non-executive director of the third Board of Directors and from the role of chairman or member of certain board committees. After reviewing the relevant recommendations and qualifications, the Board of Directors has proposed to nominate Leng Xuesong as the candidate for independent non-executive director of the third Board of Directors.

Gelonghui FinanceDec 12 05:32 ET

Express News | JPMorgan Chase & Co's Long Position in H-Shares of WuXi AppTec Decreases to 8.98% on Dec 5 From 9.42% - HKEX

ReutersDec 10 04:28 ET

0.15 billion! Wuxi AppTec invested in a French VC, adding to the European biomedical market.

① Wuxi Apptec plans to invest in the "Jeito II S.L.P." fund, with a total target scale not exceeding 1.2 billion euros, and the fund is expected to invest in 14-17 medical innovative startups. ② Previously, Wuxi Apptec planned to invest 10 million euros in another well-known biotechnology investment institution in Europe, focusing on early-stage biomedical companies in Europe.

cls.cnDec 9 05:34 ET

WuXi AppTec Subscribes for 153 Million Yuan in Investment Fund

MT NewswiresDec 9 02:35 ET